BioVie Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	2018 - 2014
Net Income	-36.29	-50.26	-26.08	-183.85	-33.78	-2.49	Upgrade
Depreciation & Amortization	0.23	0.23	0.23	0.23	0.23	0.23	Upgrade
Share-Based Compensation	4.44	6.38	6.19	3.02	0.02	0.06	Upgrade
Other Operating Activities	-3.61	3.4	0.67	116.55	14.79	-0.35	Upgrade
Operating Cash Flow	-35.23	-40.25	-18.99	-10.45	-1.63	-2.5	Upgrade
Change in Investments	12.73	-14.3	0	0	0	0	Upgrade
Investing Cash Flow	12.73	-14.3	0	0	0	0	Upgrade
Share Issuance / Repurchase	29.07	55.37	18.51	16.31	0	0	Upgrade
Debt Issued / Paid	-7.5	0	14.61	-1.39	1.33	-0.24	Upgrade
Other Financing Activities	-	-	-	-	-	3.04	Upgrade
Financing Cash Flow	21.57	55.37	33.12	14.93	1.33	2.8	Upgrade
Net Cash Flow	-0.93	0.82	14.13	4.47	-0.3	0.29	Upgrade
Free Cash Flow	-35.23	-40.25	-18.99	-10.45	-1.63	-2.5	Upgrade
Free Cash Flow Per Share	-0.79	-1.24	-0.77	-0.84	-0.33	-0.98	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).